Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Companion Animals

Set Alert for Companion Animals

Submit your nominations for the Animal Pharm Awards 2018

Subscribers have five weeks to nominate their company and their innovations in the Animal Pharm Awards for 2018.

Companion Animals Food Animals

KindredBio ahead of competitors with IL-31, mulling enquires

Kindred Biosciences believes it is ahead of competitors in developing its interleukin-31 (IL-31) antibody.

Kindred Biosciences R&D

Zoetis receives FDA authorization for poultry combination

Zoetis has gained US FDA approval for its Cyden (clopidol) and Lincomix (lincomycin) combination feed additive.

Zoetis Product Approvals

Ceva gains CVMP positive opinion for canine cardiovascular product

Ceva Santé Animale's Isemid (torasemide) has moved a step closer to European authorization after gaining a recommendation for marketing approval.

Product Approvals Pharmaceuticals

New Capnocytophaga subspecies discovered in Japan

Japanese authorities have revealed the extent of human Capnocytophaga infections over the last 24 years.

Japan Research

Dômes Pharma makes stem cell play with equity investment

Dômes Pharma has made an equity investment in fellow family-owned French company StemT Laboratory – a specialist in the veterinary stem cell therapy sector.

M&A Companion Animals

Leading Taiwanese firm builds pipeline of pet generics

Taiwan-based firm Vetnostrum is aiming to diversify its portfolio of veterinary generics in the near future, by moving further into the companion animal sector.

Taiwan Generics

Credo Biomedical aims to empower vets with POC diagnostic technology

Singapore-based Credo Biomedical is seeking global partners to take its point-of-care (POC) molecular diagnostics for companion animals to a wider sales base.

Equipment & Technology Companion Animals

Zoetis to market Revolution Plus in 2019, eyes more lifecycle innovation

Zoetis is to add to its Revolution (selamectin) canine parasiticide brand next year, by bringing a new product to market in the US.

Zoetis R&D

Zoetis to bring companion animal innovation to China in next few years

Zoetis is to add new companion animal products to its Chinese portfolio in the coming years, as the firm looks to build on the growth its swine vaccines have initiated.

China Zoetis

KindredBio sees atopic dermatitis shift to biologics, gains positive results in mAb study

Kindred Biosciences has gained positive top-line results from a pilot effectiveness study of its interleukin-31 (IL-31) antibody for the treatment of canine atopic dermatitis.

Canine Kindred Biosciences

Phyto signs up US distributor for CBD products

Phyto Animal Health has signed an exclusive distribution agreement with Liiv Organics to sell its cannabidiol (CBD) products in the US.

Deals Pharmaceuticals
See All
Advertisement
UsernamePublicRestriction

Register